Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

SVP and Chief Business Officer

See Remarks

See Remark

Chief Commercial Officer

Chief Technical Officer

SVP, Operations

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseas...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-10	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-04	Premium	bought	Premium	Premium	Premium	-
2024-03-04	Premium	sold	Premium	Premium	Premium	SVP and Chief Business Officer
2024-03-04	Premium	sold	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold	Premium	Premium	Premium	See Remark
2024-03-04	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-28	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-13	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-13	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-13	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-13	Premium	acquired	Premium	Premium	Premium	See Remark
2024-02-13	Premium	acquired	Premium	Premium	Premium	SVP and Chief Business Officer
2024-01-12	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-12	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-12	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-01-12	Premium	acquired	Premium	Premium	Premium	See Remark
2024-01-12	Premium	acquired	Premium	Premium	Premium	SVP and Chief Business Officer
2024-01-02	Premium	sold	Premium	Premium	Premium	See Remarks
2023-12-20	Premium	gifted	Premium	Premium	Premium	See Remarks
2023-12-20	Premium	gifted	Premium	Premium	Premium	See Remarks
2023-12-01	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-11-21	Premium	sold	Premium	Premium	Premium	See Remark
2023-11-18	Premium	acquired	Premium	Premium	Premium	See Remark
2023-10-24	Premium	bought	Premium	Premium	Premium	-
2023-09-27	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer

ARQT - Arcutis Biotherapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ARQT